It was 2007 when an article in the U.K. had taken Daval International Ltd. to task for not doing clinical trials on their drug, Aimspro. The article had brought up how, in seven years, only two very small trials had been done and of them, “one was inconclusive and the other was stopped early.”
Aimspro is only available in Britain under their “compassionate-use” regulations and that means, like CCSVI, patients have to use their own money to receive treatment. No health insurance companies (or state funded health regulators) will touch a non-FDA or non-MHRA approved therapy............. Read More - http://www.ms-uk.org/index.cfm/aimspro
The controversy behind goat’s blood for MS therapy
The controversy behind goat’s blood for MS therapy
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2383 Views
-
Last post by frodo
-
- 0 Replies
- 1317 Views
-
Last post by NHE
-
- 2 Replies
- 1997 Views
-
Last post by frodo
-
- 0 Replies
- 12801 Views
-
Last post by NHE
-
- 0 Replies
- 2904 Views
-
Last post by NHE
-
- 0 Replies
- 2708 Views
-
Last post by frodo
-
- 1 Replies
- 2094 Views
-
Last post by frodo
-
- 0 Replies
- 1464 Views
-
Last post by frodo
-
- 1 Replies
- 1385 Views
-
Last post by frodo